Development & Implementation of an SEC Method for Streamlined Analysis of Free Drug Related Impurities in Novel ADC Chemotypes
Time: 9:00 am
day: Day Two
Details:
• Performing a FDRI analysis is critical for ensuring ADC product safety
• Exploring how new ADC chemotypes can pose challenges with respect to FDRI method development, and may not be a good fit for platform methods
• Assessing a new SEC method that has been developed to overcomes challenges of the previous RP method and is expected to be more easily adapted for new chemotypes
